Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Values and Preferences Towards Antithrombotic Therapy in Patients with Myeloproliferative Neoplasms: A Qualitative Study

Jonah Rakoff, Shannon J. Lane, Christopher M. Hillis, Deborah M. Siegal

Blood (2022) 140 (Supplement 1): 13280–13281.

https://doi.org/10.1182/blood-2022-159638

Published: 2022

Journal Articles

The Economic Impact of Treatment Sequencing in the Management of Chronic Lymphocytic Leukemia in Canada Using Venetoclax Plus Obinutuzumab

Kimberly Guinan, Jean Lachaine, Nancy Paul Roc, Sarah-Jane Bull, Dipti Tankala, Stéphane Barakat, Christopher M. Hillis, Versha Banerji

Blood (2022) 140 (Supplement 1): 2157–2158.

https://doi.org/10.1182/blood-2022-167235

Published: 2022

Journal Articles

Fitness Assessment of Elderly Patients with AML and Outcomes

Tony HT Chen, Joshua Xu, Hassan Zahreddine, Brian Leber, Irwin Walker, Tobias Berg, Kylie L. Lepic, Parveen Wasi, Tom Kouroukis, Christopher M. Hillis, Justin Y. Lee, Dina Khalaf

Blood (2021) 138 (Supplement 1): 3379.

https://doi.org/10.1182/blood-2021-152612

Published: 2021

Journal Articles

Elucidating Barriers to Advance Care Planning in Malignant Hematology Clinics: A Single Centre Experience in Ontario, Canada

Oksana Motalo, MD, Christopher M. Hillis, MD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-139793

Published: 2020

Journal Articles

Increased Health Resource Utilization with the Introduction of Matrix for First-Line Treatment of Primary Central Nervous System Lymphoma

Dixon Pinto, Christopher M. Hillis, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-134819

Published: 2020

Journal Articles

Characterizing Frailty in Myeloproliferative Neoplasms: Baseline Results from the Orchid Study

Nicholas L Jackson Chornenki, MD, Sarah Karampatos, Darryl Leong, Deborah M Siegal, MD, Christopher M. Hillis, MD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-134557

Published: 2020

Journal Articles

The Predictive Value of Intracellular Imatinib Levels in Chronic Myeloid Leukemia

Nicholas L Jackson Chornenki, BSc, Christopher M. Hillis, MD, Isabelle Bence-Bruckler, MD, Lambert Busque, MD, Caroline Hamm, MD, Wanda Hasegawa, MD, Jeffrey H. Lipton, MD PhD, Lynn Savoie, MD, Robert Turner, MD, Anargyros Xenocostas, MD, Suzanne Kamel-Reid, BA, MA, PhD FACMG, Brian Leber, MD

Blood (2018) 132 (Supplement 1): 4250.

https://doi.org/10.1182/blood-2018-99-111294

Published: 2018

Journal Articles

Glycemic Control in Patients Treated with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review

Laura Spatafora, Breanne Golemiec, Lehana Thabane, PhD, Laura Banfield, Christopher M. Hillis, MD, Constantine Samaan, MD, Uma Athale, MD MBBS,MSc

Blood (2018) 132 (Supplement 1): 4273.

https://doi.org/10.1182/blood-2018-99-117464

Published: 2018

Journal Articles

The Real-World Treatment of Polycythemia Vera: Adherence to Treatment Guidelines and Outcomes

Nicholas L Jackson Chornenki, BSc, Chatree Chai-Adisaksopha, MD, Deborah M Siegal, MD MSc, FRCPC, Christopher M. Hillis, MD

Blood (2017) 130 (Supplement 1): 5272.

https://doi.org/10.1182/blood.V130.Suppl_1.5272.5272

Published: 2017

Journal Articles

Warfarin Resumption after Intracranial Hemorrhage: A Systematic Review and Meta-Analysis

Chatree Chai-Adisaksopha, MD, Christopher M Hillis, MD FRCPC, Daniel M. Witt, PharmD, FCCP, BCPS, Sam Schulman, MD PhD FRCPC, Mark Crowther, MD, Alfonso Iorio, MD PhD

Blood (2016) 128 (22): 3821.

https://doi.org/10.1182/blood.V128.22.3821.3821

Published: 2016

Journal Articles

Adherence to Chronic Myeloid Leukemia Monitoring and Treatment Guidelines in Canadian Registries

Christopher M Hillis, MD FRCPC, Lambert Busque, MD PhD FRCPC, Julie Stakiw, MD, Donna L. Forrest, MD FRCPC

Blood (2016) 128 (22): 3079.

https://doi.org/10.1182/blood.V128.22.3079.3079

Published: 2016

Journal Articles

Failure to Achieve Early Molecular Milestone within 3 Months Is Associated with Higher Risk of Relapse and Worse Survival after Allogeneic Hematopoietic Stem Cell Transplant for Chronic Myeloid Leukemia Patients, Especially after Tyrosine Kinase Inhibitor Failure

Dennis Dong Hwan Kim, MD PhD, Mary Lynn Savoie, MD, Isabelle Bence-Bruckler, MD FRCPC, Lothar B. Huebsch, MD, Marc Lalancette, MDFRCP-C, Christopher M. Hillis, MD FRCPC, Irwin Walker, MBBS, Donna L. Forrest, MD, Jeff H. Lipton, MD PhD

Blood (2016) 128 (22): 1907.

https://doi.org/10.1182/blood.V128.22.1907.1907

Published: 2016

Journal Articles

Pulmonary Complications in Patients Treated with Tyrosine Kinase Inhibitors, a Systematic Review and Meta-Analysis

Chatree Chai-Adisaksopha, MD, Diep Calvin, Christopher M Hillis, MD FRCPC

Blood (2015) 126 (23): 4030.

https://doi.org/10.1182/blood.V126.23.4030.4030

Published: 2015

Journal Articles

Assessing Disease Stability of Patients with Myelodysplastic Syndrome for an Age of Blood Randomized Controlled Trial: A Chart Review

Naushin S. Sholapur, BHSc, MSc (C), Christopher M Hillis, MD FRCPC, Mark A. Crowther, MD MSc, FRCPC, Brian Leber, MD, Faiza Khokhar, BHSc, MD, Richard Cook, M. Math, PhD, Ronald Barr, MD, Nancy M. Heddle, MSc, FCSMLS(D)

Blood (2015) 126 (23): 5252.

https://doi.org/10.1182/blood.V126.23.5252.5252

Published: 2015

Journal Articles

A Qualitative Research Study to Understand Post-Transfusion Well-Being in Patients with Myelodysplastic Syndromes

Naushin S. Sholapur, BHSc, MSc (C), Shannon Lane, Christopher M Hillis, MD FRCPC, Mark A. Crowther, MD MSc, FRCPC, Brian Leber, MD, Richard Cook, M. Math, PhD, Ronald Barr, MD, Nancy M. Heddle, MSc, FCSMLS(D)

Blood (2015) 126 (23): 4446.

https://doi.org/10.1182/blood.V126.23.4446.4446

Published: 2015

Journal Articles

Retrospective Analysis of Allogeneic Transplant Outcomes in Chronic Myeloid Leukemia Patients with Tyrosine Kinase Inhibitors Failure

Dennis Dong Hwan Kim, MDPhD, Isabelle Bence-Bruckler, MD FRCPC, Christopher M. Hillis, MD FRCPC, Irwin Walker, MBBS, Suzanne Kamel-Reid, PhD, Jeffrey H. Lipton, MD PhD

Blood (2014) 124 (21): 4554.

https://doi.org/10.1182/blood.V124.21.4554.4554

Published: 2014

Journal Articles

Thromboembolic Events, Recurrent Gastrointestinal Bleeding and Mortality after Resuming Anticoagulant Following Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis

Chatree Chai-Adisaksopha, MD, Christopher M. Hillis, MD FRCPC, Mark A. Crowther, MD

Blood (2014) 124 (21): 2799.

https://doi.org/10.1182/blood.V124.21.2799.2799

Published: 2014

Journal Articles

A Systematic Review of Definitions and Reporting of Bleeding Outcome Measures in Hemophilia

Chatree Chai-Adisaksopha, MD, Christopher M. Hillis, MD FRCPC, Lehana Thabane, PhD, Alfonso Iorio, MD PhD

Blood (2014) 124 (21): 2821.

https://doi.org/10.1182/blood.V124.21.2821.2821

Published: 2014

NARROW

Values and Preferences Towards Antithrombotic Therapy in Patients with Myeloproliferative Neoplasms: A Qualitative Study

The Economic Impact of Treatment Sequencing in the Management of Chronic Lymphocytic Leukemia in Canada Using Venetoclax Plus Obinutuzumab

Fitness Assessment of Elderly Patients with AML and Outcomes

Elucidating Barriers to Advance Care Planning in Malignant Hematology Clinics: A Single Centre Experience in Ontario, Canada

Increased Health Resource Utilization with the Introduction of Matrix for First-Line Treatment of Primary Central Nervous System Lymphoma

Characterizing Frailty in Myeloproliferative Neoplasms: Baseline Results from the Orchid Study

The Predictive Value of Intracellular Imatinib Levels in Chronic Myeloid Leukemia

Glycemic Control in Patients Treated with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review

The Real-World Treatment of Polycythemia Vera: Adherence to Treatment Guidelines and Outcomes

Warfarin Resumption after Intracranial Hemorrhage: A Systematic Review and Meta-Analysis

Adherence to Chronic Myeloid Leukemia Monitoring and Treatment Guidelines in Canadian Registries

Failure to Achieve Early Molecular Milestone within 3 Months Is Associated with Higher Risk of Relapse and Worse Survival after Allogeneic Hematopoietic Stem Cell Transplant for Chronic Myeloid Leukemia Patients, Especially after Tyrosine Kinase Inhibitor Failure

Pulmonary Complications in Patients Treated with Tyrosine Kinase Inhibitors, a Systematic Review and Meta-Analysis

Assessing Disease Stability of Patients with Myelodysplastic Syndrome for an Age of Blood Randomized Controlled Trial: A Chart Review

A Qualitative Research Study to Understand Post-Transfusion Well-Being in Patients with Myelodysplastic Syndromes

Retrospective Analysis of Allogeneic Transplant Outcomes in Chronic Myeloid Leukemia Patients with Tyrosine Kinase Inhibitors Failure

Thromboembolic Events, Recurrent Gastrointestinal Bleeding and Mortality after Resuming Anticoagulant Following Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis

A Systematic Review of Definitions and Reporting of Bleeding Outcome Measures in Hemophilia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only